Teladoc Health, Inc. Financial Ratios — TDOC Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-36.25	-27.04	-12.35	-9.75	-5.74	-2.69	-148.85	-9.51	-52.46	-13.93
Return on Assets (%)	- -	-28.58	-36.08	-27.83	-18.93	-8.25	-6.31	-5.01	-2.42	-123.73	-5.04	-25.32	-6.28
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	78.97	77.19	72.81	74.04	73.58	69.2	66.66	64.27	68.01	69.09	70.8	70.76	69.5
EBITDA Margin (%)	-25.7	-29.48	-65.8	-44.17	-24.13	-8.44	-6.41	-39.15	-2.26	-556.14	3.85	-24.83	4.49
Operating Margin (%)	-29.48	-34.35	-71.38	-45.23	-26.66	-15.78	-13.34	-38.23	-11.76	-9.45	-8.09	-8.13	-6.46
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	19.09	3.11	8.62	- -	- -
Pretax Margin (%)	-29.76	-38.25	-74.93	-59.85	-45.87	-23.2	-19.78	-52.65	-18.92	-567.69	-8.44	-38.67	-9.31
Profit Margin (%)	-30.24	-39.14	-74.98	-60.26	-45.77	-23.23	-17.87	-44.35	-21.09	-567.53	-8.47	-38.97	-7.92
Net Income to Common Margin (%)	-49.43	-46.23	-74.98	-60.26	-45.77	-23.23	-17.87	-44.35	-21.09	-567.53	-8.47	-38.97	-7.92
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	38.83	15.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-36.25	-27.04	-12.35	-9.75	-5.74	-2.69	-148.85	-9.51	-52.46	-13.93

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	3	26	26	44	207	415	470	1,477	1,280	1,587	1,592	1,585	1,040
ST Debt	- -	1	1	2	- -	- -	5	54	13	14	11	561	11
LT Debt	3	25	25	42	207	415	465	1,423	1,267	1,573	1,582	1,024	1,029
Total Debt/EBITDA	-0.59	-2.02	-0.52	-0.82	-3.68	-11.76	-13.26	-3.45	-27.82	-0.12	15.9	-2.48	9.17
Net Debt/EBITDA	0.04	1.6	0.56	0.1	-2.92	0.26	2.08	-1.61	-7.22	-0.05	4.14	-0.38	1.88
Total Debt/EBIT	-0.51	-1.71	-0.47	-0.71	-2.75	-5.85	-5.85	-2.92	-4.82	-0.12	-6.41	-1.55	-3.96
Net Debt/EBIT	0.04	1.36	0.51	0.09	-2.18	0.13	0.92	-1.36	-1.25	-0.05	-1.67	-0.24	-0.81
EBITDA to Interest Expense	-91.34	-8.56	-23.16	-21.02	-3.22	-1.35	-1.21	-7.14	-0.57	-609.98	4.5	-26.81	5.76
EBITDA-CapEx/Interest Expense	-114.45	-9.72	-26.71	-22.34	-3.53	-1.67	-1.58	-7.51	-1.25	-609.98	4.5	-26.81	4.26
EBIT to Interest Expense	-104.8	-9.98	-25.12	-21.52	-3.56	-2.53	-2.51	-6.98	-2.95	-10.36	-9.45	-8.77	-8.29
Interest Expense	- -	1	2	3	17	26	29	60	81	22	22	24	20
Common Equity/Total Assets	-192.07	-70.43	77.73	76.03	67.8	66.27	63.26	89.46	90.48	53.11	52.96	42.4	48.48
Long-Term Debt/Equity (%)	15.74	47.04	14.13	18.38	37.1	40.93	45.9	8.96	7.9	68.18	67.99	68.65	74.27
Long-Term Debt/Capital (%)	13.6	31.65	12.3	15.41	27.06	29.04	31.35	8.2	7.32	40.4	40.36	33.28	42.42
Long-Term Debt/Total Assets (%)	10.95	27.27	10.98	13.97	25.15	27.12	29.04	8.01	7.15	36.21	36.01	29.11	36
Total Debt/Equity (%)	15.74	48.61	14.83	19.24	37.1	40.93	46.4	9.3	7.98	68.77	68.45	106.27	75.06
Total Debt/Capital (%)	13.6	32.71	12.91	16.14	27.06	29.04	31.69	8.51	7.39	40.75	40.64	51.52	42.88
Total Debt/Total Assets (%)	10.95	28.17	11.52	14.63	25.15	27.12	29.35	8.32	7.22	36.52	36.25	45.06	36.39
Net Debt to Equity	-1.11	-38.63	-16.01	-2.42	29.44	-0.92	-7.29	4.34	2.07	26.74	17.84	16.35	15.43
Net Debt/Capital (%)	-1.13	-62.95	-19.06	-2.48	22.75	-0.93	-7.62	4.14	2.02	20.73	14.85	13.72	13
EBITDA	-5	-13	-51	-54	-56	-35	-35	-428	-46	-13,385	100	-638	113
EBITDA-CapEx	-6	-15	-59	-58	-62	-44	-46	-450	-101	-13,385	100	-638	84
Operating Income (Loss)	-6	-15	-55	-56	-62	-66	-74	-418	-239	-227	-211	-209	-163

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.62	4.5	7.64	3.12	3.03	7.66	5.73	2.36	2.71	2.3	2.67	1.38	1.93
Current Ratio	1.33	5.28	8.43	3.93	3.87	8.53	6.52	3.19	3.7	3.29	3.54	1.77	2.77
Quick Ratio	1.18	5.19	8.31	3.78	3.7	8.36	6.37	2.87	3.28	2.89	3.22	1.62	2.43
CFO/Avg Current Liab	- -	-1.47	-3.33	-2.66	-1.12	-0.09	0.39	-0.25	0.58	0.52	0.85	0.43	0.44
Common Equity/Total Assets	-192.07	-70.43	77.73	76.03	67.8	66.27	63.26	89.46	90.48	53.11	52.96	42.4	48.48
Long-Term Debt/Equity (%)	15.74	47.04	14.13	18.38	37.1	40.93	45.9	8.96	7.9	68.18	67.99	68.65	74.27
Long-Term Debt/Capital (%)	13.6	31.65	12.3	15.41	27.06	29.04	31.35	8.2	7.32	40.4	40.36	33.28	42.42
Long-Term Debt/Total Assets (%)	10.95	27.27	10.98	13.97	25.15	27.12	29.04	8.01	7.15	36.21	36.01	29.11	36
Total Debt/Equity (%)	15.74	48.61	14.83	19.24	37.1	40.93	46.4	9.3	7.98	68.77	68.45	106.27	75.06
Total Debt/Capital (%)	13.6	32.71	12.91	16.14	27.06	29.04	31.69	8.51	7.39	40.75	40.64	51.52	42.88
Total Debt/Total Assets (%)	10.95	28.17	11.52	14.63	25.15	27.12	29.35	8.32	7.22	36.52	36.25	45.06	36.39
CFO/Total Liabilities	-72.66	-29.42	-92.2	-71.26	-12.97	-0.94	5.07	-2.86	11.49	9.29	16.94	14.5	19.99
CFO/CapEx	-4.68	-6.55	-6.04	-15.2	-6.24	-0.58	2.74	-2.43	3.5	- -	- -	- -	9.95
Altman's Z-Score	- -	- -	7.31	3.27	3.23	4.42	6.52	8.94	5.48	-11.58	-10	-10.62	-15.26

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	9.21	8.16	9.5	11.41	11.83	11.01	9.67	12.02	12.68	12.16	11.91	12.43
Days Sales Outstanding	- -	39.62	44.75	38.44	32	30.86	33.15	37.74	30.37	28.78	30.01	30.65	29.36
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	13.84	10.04	11.5	17.7	22.21	20.21
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	26.38	36.37	31.75	20.62	16.43	18.06
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	16.24	14.3	15.32	16.06	19.8	19.03
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	22.48	25.53	23.83	22.73	18.44	19.18
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	41.64	41.2	36.7	27.9	28.65	28.23
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	11.36	-6	-2.97	9.4	14.22	11.3
Inventories	- -	- -	- -	- -	- -	- -	- -	56	73	56	30	38	38
Raw Materials	- -	- -	- -	- -	- -	- -	- -	20	29	26	9	14	14
Work In Process	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	1	1
Finished Goods	- -	- -	- -	- -	- -	- -	- -	35	49	30	20	23	24
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	692	762	2,144	3,495	6,092	30,050	14,734	3,851	3,591	1,576	1,248
- Cash & Cash Equivalents	3	46	55	50	43	424	514	733	893	918	1,124	1,298	781
+ Preferred Equity and Hybrid Capital	72	118	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	26	26	44	207	415	470	1,477	1,280	1,587	1,592	1,585	1,040
Enterprise Value	- -	- -	581	741	2,230	3,432	6,045	30,740	15,118	4,520	4,060	1,863	1,507
Total Capital	22	79	205	275	766	1,428	1,485	17,361	17,326	3,895	3,918	3,076	2,426
Total Debt/Capital (%)	13.6	32.71	12.91	16.14	27.06	29.04	31.69	8.51	7.39	40.75	40.64	51.52	42.88
Total Debt / EV	- -	- -	0.05	0.06	0.09	0.12	0.08	0.05	0.08	0.35	0.39	0.85	0.69
EV/Sales	- -	- -	7.51	6.02	9.56	8.21	10.93	28.1	7.44	1.88	1.56	0.72	0.6
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	40.53	- -	13.28
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	358	698	1,932	3,264	6,015	18,098	14,410	3,818	3,495	1,550	1,234
Diluted Enterprise Value	- -	- -	247	677	2,017	3,200	5,968	18,788	14,794	4,487	3,963	1,837	1,493
EV per Share	- -	- -	15.08	16.04	36.23	48.66	83.08	204.55	94.21	27.76	24.36	10.74	8.45
TTM Sales	20	44	77	123	233	418	553	1,094	2,033	2,407	2,602	2,570	2,530
TTM EBITDA	-5	-13	-51	-54	-56	-35	-35	-428	-46	-13,385	100	-638	113
TTM Operating Income	-6	-15	-55	-56	-62	-66	-74	-418	-239	-227	-211	-209	-163
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-6.5	-12.63	-48.34	-246.02	317.09	-239.62	103.98	20.17	9.98	5.28	4.66
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	581	741	2,230	3,432	6,045	30,740	15,118	4,520	4,060	1,863	1,507
Low Price	- -	- -	15.32	9.08	15.65	30.88	46	81.3	87.27	22.35	15.02	6.76	6.35
EV/Sales	- -	- -	7.51	6.02	9.56	8.21	10.93	28.1	7.44	1.88	1.56	0.72	0.6
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	40.53	- -	13.28
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	3.87	3.3	3.84	3.45	6.01	1.89	0.92	1.67	1.54	1.06	0.9
Price/Book Value Average	- -	- -	4.9	3.02	3.19	3.82	4.69	1.68	1.64	3.1	1.68	1.4	1.06
Price/Book Value High	- -	- -	7.64	4.16	4.17	6.2	6.19	2.39	3.08	6.75	2.46	2.62	1.96
Price/Book Value Low	- -	- -	3.31	1.82	1.72	2.15	3.3	0.77	0.87	1.58	1.08	0.79	0.82
Price/Tangible Book Value	- -	- -	6.47	42.8	-21.57	122.53	143.36	-41.83	-39.96	-6.4	-8.45	-7.05	-6.42
Price/Tangible Book Value Average	- -	- -	8.19	39.17	-17.96	135.64	111.97	-37.06	-71.37	-11.9	-9.18	-9.31	-7.54
Price/Tangible Book Value High	- -	- -	12.76	53.96	-23.46	220.11	147.77	-52.93	-134.05	-25.88	-13.48	-17.49	-13.94
Price/Tangible Book Value Low	- -	- -	5.52	23.55	-9.69	76.32	78.77	-17.01	-37.98	-6.04	-5.89	-5.25	-5.82
Price/Sales	- -	- -	4.62	5.67	8.28	7.81	10.87	16.54	7.09	1.59	1.34	0.6	0.49
Price/Sales Average	- -	- -	5.85	5.19	6.89	8.65	8.49	14.66	12.66	2.95	1.46	0.8	0.57
Price/Sales High	- -	- -	9.12	7.15	9.01	14.03	11.21	20.93	23.78	6.42	2.14	1.5	1.06
Price/Sales Low	- -	- -	3.94	3.12	3.72	4.86	5.97	6.73	6.74	1.5	0.94	0.45	0.44
Price/Cash Flow	- -	- -	-7.58	-13.46	-56.09	-671.59	201.37	-338.22	74.28	20.17	9.98	5.28	4.19
Price/Cash Flow Average	- -	- -	-9.6	-12.32	-46.7	-743.46	157.29	-299.64	132.66	37.53	10.85	6.97	4.93
Price/Cash Flow High	- -	- -	-14.95	-16.97	-60.99	-1,206.43	207.58	-427.93	249.17	81.64	15.92	13.09	9.11
Price/Cash Flow Low	- -	- -	-6.47	-7.41	-25.19	-418.3	110.64	-137.51	70.6	19.06	6.96	3.93	3.8
Price/Free Cash Flow Average	- -	- -	-8.23	-11.56	-40.25	-272.35	247.66	-212.29	185.69	37.53	10.85	6.97	5.48
Price/Free Cash Flow High	- -	- -	-12.83	-15.93	-52.58	-441.94	326.86	-303.18	348.78	81.64	15.92	13.09	10.12
Price/Free Cash Flow Low	- -	- -	-5.55	-6.95	-21.71	-153.23	174.22	-97.42	98.82	19.06	6.96	3.93	4.23
EV/Sales Average	- -	- -	9.89	5.49	8.02	9.11	8.51	24.97	13.13	3.25	1.68	0.92	0.68
EV/Sales High	- -	- -	16.2	7.63	10.36	14.87	11.26	35.39	24.5	6.75	2.38	1.63	1.17
EV/Sales Low	- -	- -	6.19	3.23	4.49	5.06	5.97	11.8	7.08	1.79	1.14	0.57	0.55
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	43.63	- -	15.21
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	61.85	- -	26.18
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	29.67	- -	12.26
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Last Price	- -	- -	17.96	16.5	34.85	49.57	83.72	199.96	91.82	23.65	21.55	9.09	7
High Price	- -	- -	35.42	20.8	37.9	89.05	86.3	253	308	95.71	34.36	22.54	15.21
Enterprise Value Average	- -	- -	765	676	1,871	3,806	4,711	27,313	26,698	7,834	4,370	2,366	1,726
Enterprise Value High	- -	- -	1,254	940	2,417	6,215	6,233	38,711	49,809	16,254	6,195	4,195	2,971
Enterprise Value Low	- -	- -	479	398	1,048	2,113	3,300	12,908	14,388	4,308	2,972	1,459	1,391

Shares Outstanding	36	36	39	46	62	71	73	150	160	163	167	173	178
Diluted Weighted Avg Shares	152	152	20	42	55	66	72	91	157	161	162	171	176
Basic Weighted Avg Shares	152	152	20	42	55	66	72	91	157	161	162	171	176
Revenue per Share	0.13	0.29	3.89	2.91	4.21	6.35	7.7	12.09	12.95	14.91	16.05	15.07	14.36
EBITDA per Share	-0.03	-0.08	-2.56	-1.28	-1.02	-0.54	-0.49	-4.73	-0.29	-82.9	0.62	-3.74	0.64
Operating Income per Share	-0.04	-0.1	-2.77	-1.32	-1.12	-1	-1.03	-4.62	-1.52	-1.41	-1.3	-1.22	-0.93
Basic EPS, GAAP	-0.06	-0.13	-2.91	-1.75	-1.93	-1.47	-1.38	-5.36	-2.73	-84.6	-1.36	-5.87	-1.14
Basic EPS from Cont Ops	-0.04	-0.11	-2.91	-1.75	-1.93	-1.47	-1.38	-5.36	-2.73	-84.6	-1.36	-5.87	-1.14
Diluted EPS, GAAP	-0.06	-0.13	-2.91	-1.75	-1.93	-1.47	-1.38	-5.36	-2.73	-84.6	-1.36	-5.87	-1.14
Diluted EPS from Cont Ops	-0.04	-0.11	-2.91	-1.75	-1.93	-1.47	-1.38	-5.36	-2.73	-84.6	-1.36	-5.87	-1.14
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.04	-0.07	-2.37	-1.23	-0.62	-0.07	0.42	-0.59	1.24	1.17	2.16	1.72	1.67
Free Cash Flow per Basic Share	-0.05	-0.09	-2.76	-1.31	-0.72	-0.2	0.26	-0.83	0.88	1.17	2.16	1.72	1.5
Cash & Equivalents per Share	0.09	1.3	3.57	1.42	1.99	6.79	7.11	5.23	5.58	5.64	6.74	7.49	4.38
Book Value per Share	-1.47	-1.81	4.64	5	9.08	14.37	13.94	105.69	99.99	14.17	13.96	8.6	7.77
Tangible Book Value per Share	-2.03	-2.81	2.78	0.39	-1.62	0.4	0.58	-4.78	-2.3	-3.7	-2.55	-1.29	-1.09

Teladoc Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)